Achievement of clinical remission in patients with juvenile idiopathic arthritis under a 2-10-year Etanercept exposure. [electronic resource]
- Clinical rheumatology Aug 2013
- 1191-7 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1434-9949
10.1007/s10067-013-2261-z doi
Adolescent Antirheumatic Agents--therapeutic use Arthritis, Juvenile--drug therapy Child Etanercept Female Humans Immunoglobulin G--therapeutic use Joints--pathology Male Receptors, Tumor Necrosis Factor--therapeutic use Registries Remission Induction Retrospective Studies Severity of Illness Index Time Factors Treatment Outcome Uveitis--diagnosis